ersonal use only

AnteoTech Ltd (ASX:ADO)

Company Presentation

10 March 2022

DISCLAIMER

Important Information

The purpose of the presentation is to provide an update of the business of AnteoTech Ltd (ASX:ADO) (AnteoTech). These slides have been prepared as a presentation aid only and the information they contain may require further explanation and/or clarification. Accordingly, these slides and the information they contain should be read in conjunction with past and future announcements made by AnteoTech and should not be relied upon as an independent source of information. Please contact AnteoTech and/or refer to the Company's website for further information.

The views expressed in this presentation contain information derived from publicly available sources that have not been independently verified. No representation or warranty is made as to the accuracy, completeness or reliability of the information.

Forward-looking statements

The presentation may contain certain "forward-looking statements". Forward-looking statements can generally be identified by the use of forward-looking words such as "may", "will", "would", "could",

"expect", "intend", "plan", "aim", "estimate", "target", "anticipate", "believe", "continue", "objectives", "outlook", "guidance" or other similar words, and include statements regarding AnteoTech's intent,

onlybelief or current expectations with respect to AnteoTech's business and operations, market conditions, results of operations and financial condition, capital adequacy and risk management. These forward

looking statements should not be relied upon as a representation or warranty, express or implied, as to future matters. Prospective financial information has been based on current expectations about

future events and is, however, subject to risks, uncertainties, contingencies and assumptions that could cause actual results to differ materially from the expectations described in such prospective

information. AnteoTech disclaims any obligation to update any forward looking statement to reflect events or circumstances after the date of the presentation, subject to the disclosure requirements

applicable to the Group.

Not an offer of securities

This presentation should not be relied on as a recommendation or forecast by AnteoTech Nothing in this presentation should be construed as either an offer to sell or a solicitation of an offer to buy or sell

shares in any jurisdiction. The information in this presentation is not intended to be relied upon as advice to investors or potential investors and does not take into account your financial objectives,

usesituation or needs. Investors should consult with their own legal, tax, business and/or financial advisors in connection with any investment decision

EuGeni SARS-CoV-2 Ag RDT - CE Marked - not available in other jurisdictions

ersonal

• The COVID-19 rapid antigen test (RAT) must not be supplied for the purpose of self-testing

• The COVID-19 RAT must only be used by relevant practitioners, or persons under their supervision, who are trained in the correct use of the goods and the interpretation of the test results

• Negative test results do not exclude infection with COVID-19 (so face masks, social distancing and good hygiene practice must be maintained)

• Positive test results or symptomatic persons require immediate confirmatory testing with a polymerase chain reaction (PCR) test.

10 March 2022

2

ANTEOTECH - TODAY

AnteoTech is commercialising innovative patented nano-technology - with lucrative revenue opportunities across two key growth sectors: Point of Care (POC) diagnostics and Lithium-ion(Li-io) battery market

ersonal use only

STRONG IP

POSITION

HIGH IMPACT

SECTORS

Unique, proprietary nano-polymer technology

  • Proven product in market - AnteoBind
  • Core technology has delivered proof of concept applications across Life Science & Energy applications

Developing solutions in rapid growth, high impact sectors

  • Improving POC testing & assay development in diagnostics, drug development
  • Improving Li-ion battery energy storage through enhanced silicon integration

GROWTH MARKETS

Active in growth markets

  • POC diagnostics - Lateral Flow Assay (LFA) market forecast to grow to US$12.19b by 2027
  • Lithium-ionbattery market - forecast to hit US$130 Billion by 2030.2

Ready to deliver - short to medium term opportunity

  • Life Science - Growing distribution network and pipeline of tests.
  • Li-ionbatteries - strong network of collaborators spanning battery value chain

10 March 2022

1. Source: Market Forecast:Lateral Flow Assay Market - Growth, Trends,COVID-19Impact, and Forecasts (2021 - 2027)Mordor Intelligence

2. Source: International Energy Agency World Energy Outlook 2021

3

CORPORATE SNAPSHOT

Headquartered in Brisbane, Australia

CORPORATE OVERVIEW: onlyASX code

Cash (as at 31 Dec 2021) Market Cap (at $0.18/per share) 52 week low - high ($/share)

Shares on issue

useDebt

Board and management holding (%)

Top 20 holding (%):

BOARD & MANAGEMENT :

Chairman ersonalChief Executive Officer

Non-Executive Director

Non-Executive Director

Non-Executive Director

Non-Executive Director

CFO and Company Secretary

10 March 2022

As at 4/03/2022

ADO $16.61m $397m

0.155 - 0.495

1,985,499,755 Nil

4.02%

28.63%

Dr Jack Hamilton

Derek Thomson

Dr Geoff Cumming

Glenda McLaughlin

Christopher Parker

Dr Katherine Woodthorpe AO

Tim Pritchard

SHARE PRICE & VOLUME (MARCH 2021 - MARCH 2022)

0.5

40

0.45

35

0.4

30

0.35

$ 0.3

25

Millions

0.25

20

0.2

15

0.15

10

0.1

0.05

5

0

0

Volume

Close

As at 4 March 2022

4

POSITIONED FOR GROWTH

A strong internal capability and an expanding network of international distributors, partners and collaborators positions AnteoTech for growth.

ersonal use only

10 March 2022

Capability

Strong Scientific Team

  • 18 Scientists across Energy
    • Life Science
    • 13 PhD's
  • Quality & Compliance Team
    • Clinical Study Manager

Collaboration

International Network

  • Scientific, manufacturing & industry
    collaboration network spanning
    whole battery value chain

Manufacturing

32 Million test capacity

    • Spanish Manufacturing
  • Australian Manufacturing
    • mid 2022
  • International expansion as

  • demand increases

Marketing & Sales

Customer Engagement Focus

  • Senior marketing

executives (Australia/ Europe and India)

  • Sales & customer support
    team in Brisbane
      • 2 PR firms
    • Creative agency

Distribution

Growing Distribution Network

    • 9 Distributors
  • 17 Territories in Europe

  • and SE Asia

R&D Innovation

Ongoing Reader Development

  • Testing of new readers targeting new
    segments.

IP Development

  • Securing IP through new
    patent applications
  • 5 new provisional patent
    applications filed in 2021 & 3 in 2022

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Anteotech Limited published this content on 10 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 March 2022 03:22:08 UTC.